Fundraising Fox
/People
Sign in

Brett Zbar

Investor

Global Head of Life Sciences at General Atlantic

New York, New York

Writes $100K – $5M checks · typically $1.5M

Find your path to Brett

1,055 people in our graph can introduce you to Brett.

Each arrow is one introduction. Sign up to fill in the first one.

Ask Lloyd Appel to introduce you to Brett

You →Lloyd · together at Aisling Capital (2008–2014) →Brett

Ask Jamie Chen to introduce you to Brett

You →Jamie · 3 people · together at Foresite Capital →Brett

Ask Sam Okafor to introduce you to Brett

You →Sam · together at Johns Hopkins Hospital →Brett

Sign up to find every way you can get introduced to Brett

  • Your email: the people you already email who know Brett
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with Brett
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Sign up with GoogleAlready have an account? Log in

About

Brett Zbar is a Managing Director and Global Head of Life Sciences at General Atlantic, which he joined in 2020. He previously was a Managing Director at Foresite Capital and a Partner at Aisling Capital, focusing on healthcare and life sciences companies, and earlier worked in the Pharmaceuticals and Medical Products practice at McKinsey & Company. He holds an M.D. from Harvard Medical School and a B.A. from Yale University, and completed an internal medicine internship at Johns Hopkins Hospital.

Invests in

BiotechDigital HealthHealthtechMedical Devices

Experience

  1. General AtlanticManaging Director and Global Head of Life Sciencescurrent2020 — presentNew York, United States
  2. Foresite Capital ManagementManaging Director2015 — 2020Greater New York City Area
  3. Aisling Capital LLCPartner2004 — 2014
  4. McKinsey & CompanyAssociate Principal1999 — 2004
  5. Johns Hopkins HospitalOsler Medical Housestaff1998 — 1999Department of Medicine

Skills & more

Corporate Development41Mergers3Start-ups15Venture Capital62Management Consulting5Emerging Markets5Growth Capital3M&A experience2LBO3Valuation8Market Entry1Business Development4
+8 moreEntrepreneurshipDue DiligenceCommercializationFinancial ModelingStrategyBusiness StrategyPrivate EquityBiotechnology

From Brett's professional profile.

Investments

Board seats

AragonCatalentConnectiveRxKinnate BiopharmaORIC PharmaceuticalsPeloton TherapeuticsPharvarisPlanet BiopharmaceuticalsReplimuneSeragonSignant HealthTurning Point TherapeuticsVenatoRx Pharmaceuticals

Investor

AllonniaAragon PharmaceuticalsCentessa PharmaceuticalsExpedition TherapeuticsJavara ResearchKinnate BiopharmaPharvarisReplimune GroupSeaport TherapeuticsVENATORX PHARMACEUTICALS INCVerdiva Bio

Sources: the firm's website · curated public sources.

Colleagues at General Atlantic

Aanchal Chadha
Analyst at General Atlantic
Aaron Goldman
Managing Director at General Atlantic
Addison Liang
Senior Associate at General Atlantic
Ade Okuwoga
Senior Associate at General Atlantic
Adrianna Ma
Executive Officer at General Atlantic
Alan Vergel de Dios
Principal at General Atlantic
Alex Baungaard
Vice President at General Atlantic
Alex Crisses
Managing Director at General Atlantic

Network9

Anton LevyScout
Managing Director at General Atlantic
Steven DenningScout
Investor at General Atlantic
Vinay TrivediScout
Investor at General Atlantic
Aaron Goldman
Managing Director at General Atlantic
Alex Crisses
Managing Director at General Atlantic
Andrew Crawford
Managing Director at General Atlantic
Andrew Ferrer
Managing Director at General Atlantic
Anish Batlaw
Managing Director at General Atlantic
Ben Sherman
Principal at General Atlantic

Investors connected to Brett in public investor directories — a warm-intro map.

Frequently asked questions

Who is Brett Zbar?
Brett Zbar is a Managing Director and Global Head of Life Sciences at General Atlantic, which he joined in 2020. He previously was a Managing Director at Foresite Capital and a Partner at Aisling Capital, focusing on healthcare and life sciences companies, and earlier worked in the Pharmaceuticals and Medical Products practice at McKinsey & Company. He holds an M.D. from Harvard Medical School and a B.A. from Yale University, and completed an internal medicine internship at Johns Hopkins Hospital.
Where does Brett Zbar work?
Brett Zbar is Global Head of Life Sciences at General Atlantic.
What does Brett Zbar invest in?
Brett Zbar invests in Biotech, Digital Health, Healthtech, Medical Devices.
What check size does Brett Zbar write?
Brett Zbar typically writes checks of $100K – $5M.
What boards does Brett Zbar sit on?
Brett Zbar holds tracked board seats at Aragon, Catalent, ConnectiveRx, Kinnate Biopharma, ORIC Pharmaceuticals, Peloton Therapeutics, Pharvaris, Planet Biopharmaceuticals, Replimune, Seragon.
What companies has Brett Zbar invested in?
Investments tracked here include Allonnia, Aragon Pharmaceuticals, Centessa Pharmaceuticals, Expedition Therapeutics, Javara Research, Kinnate Biopharma, Pharvaris, Replimune Group, Seaport Therapeutics, VENATORX PHARMACEUTICALS INC, Verdiva Bio.
Where did Brett Zbar go to school?
Brett Zbar studied at Harvard Medical School (MD, Medicine); Yale University (BA, Molecular Biophysics and Biochemistry; English).

Same school

Shared employers